Arseus NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Arseus NV Acquires Freedom Pharmaceuticals
Arseus NV announced the acquisition of Freedom Pharmaceuticals, a supplier of pharmaceutical raw materials, excipients, bases and capsules to independent compounding pharmacies throughout the United States. Freedom Pharmaceuticals will be consolidated as of April 1, 2013. Financial terms of the transaction were not disclosed.
Latest Key Developments in Medical
- YOOX SpA enters FTSE MIB of Borsa Italiana on Dec. 23 and DiaSorin SpA and Parmalat exit-Reuters
- Landauer Inc gives FY 2014 guidance; earnings guidance below analysts' estimates
- Baxter International Inc files for pediatric indication of RIXUBIS
- Covidien PLC announces definitive agreement to acquire Given Imaging Ltd
- Share this
- Digg this